Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768118 · ClinicalTrials.gov registry record · NA
A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
A NA study of Healthy, no Evidence of Disease, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT00768118: Completed NA study of Healthy, no Evidence of Disease, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00768118 is a NA study of Healthy, no Evidence of Disease that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 11 participants, below the 176-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00768118, a NA study of Healthy, no Evidence of Disease, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Studying samples of blood and urine from healthy participants receiving antioxidant nutritional supplements may help doctors identify changes in biomarkers related to oxidative stress. PURPOSE: This clinical trial is studying how well a nutritional supplement capsule containing curcumin, green tea extract, Polygonum cuspidatum extract, and soybean extract works in healthy participants.
Primary Outcome
The target accrual goal is 15 subjects. It is hoped that of those 15, at least 10 will be intervention compliant, and provide both planned blood samples. NF-kB levels will be measured using a supershift assay, which tests the specificity and level of NF-kB in the sample by measuring the optical density of a scan. With 10 patients, the mean difference in blood lymphocyte NF-kB level could be estimated to within 0.44 standard 7 deviations, with 80% confidence. That is reasonable precision and conf
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- DIETARY_SUPPLEMENT curcumin/green tea extract/Polygonum cuspidatum extract/soybean extract capsule
- GENETIC electrophoretic mobility shift assay
Study Locations (1)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00768118 record still lists
NCT00768118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 176-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Healthy, no Evidence of Disease appearing as the primary indexed condition, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00768118 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00768118 about?
NCT00768118 is a clinical study titled "A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants". RATIONALE: Studying samples of blood and urine from healthy participants receiving antioxidant nutritional supplements may help doctors identify changes in biomarkers related to oxidative stress. PURPOSE: This clinical trial is studying how well a nutritional supplement capsule containing curcumin,...
What is the current status of trial NCT00768118?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-04. Estimated completion is 2008-09.
What conditions does trial NCT00768118 study?
This clinical trial studies the following conditions: Healthy, no Evidence of Disease.
What interventions are being tested in trial NCT00768118?
The interventions under investigation include: laboratory biomarker analysis (OTHER), curcumin/green tea extract/Polygonum cuspidatum extract/soybean extract capsule (DIETARY_SUPPLEMENT), electrophoretic mobility shift assay (GENETIC).
Who is sponsoring clinical trial NCT00768118?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00768118 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy, no Evidence of Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00768118's enrollment target sits among peer trials
11 12th of 11 the lowest of 11 other Healthy, no Evidence of Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy, no Evidence of Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
COMPLETED · NA
-
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
COMPLETED · NA
-
Studying Different Formulations of SR13668 in Healthy Volunteers
COMPLETED · Phase 1
-
Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families
COMPLETED
-
Diindolylmethane in Healthy Volunteers
COMPLETED · Phase 1
-
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia